Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for marketing & advertising industry professionals · Wednesday, June 23, 2021 · 544,532,874 Articles · 3+ Million Readers

T2 Biosystems to Present at the Jefferies 2018 Global Healthcare Conference

/EIN News/ -- LEXINGTON, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, president and chief executive officer, is scheduled to present at the Jefferies 2018 Global Healthcare Conference. The conference is being held June 5-8 at the Grand Hyatt Hotel in New York.

Mr. McDonough is scheduled to present on Tuesday, June 5, 2018 at 4:30 p.m. ET and will be available for one-on-one meetings during the conference. The presentation will be webcast live and available for replay and may be accessed by visiting the Investors/Events & Presentations section of the Company’s website at www.t2biosystems.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 90 days following the presentation.

About T2 Biosystems

T2 Biosystems, an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, T2Candida® Panel, and T2Bacteria® Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including products for the detection of additional species and antibiotic resistance markers of sepsis pathogens, and tests for Lyme disease. For more information, please visit www.t2biosystems.com.

Media Contact:
Tom Langford, Feinstein Kean Healthcare
tom.langford@fkhealth.com
617-761-6775

Investor Contact:
Matthew Clawson, W2O Group
mclawson@w2ogroup.com
949-370-8500 

Primary Logo

Powered by EIN News
Distribution channels: Technology


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release